Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 55
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

National citation patterns of NEJM, The Lancet, JAMA and The BMJ in the lay press: a quantitative content analysis

  • Casino, Gonzalo, 1961-
  • Rius, Roser
  • Cobo Valeri, Erik
Objectives: To analyse the total number of newspaper articles citing the four leading general medical journals and to describe national citation patterns.Design: Quantitative content analysis.Setting/sample: Full text of 22 general newspapers in 14 countries over the period 2008–2015, collected from LexisNexis. The 14 countries have been categorised into four regions: the USA, the UK, Western World (European countries other than the UK, and Australia, New Zealand and Canada) and Rest of the World (other countries). Main outcome measure: Press citations of four medical journals (two American: NEJM and JAMA; and two British: The Lancet and The BMJ) in 22 newspapers. Results: British and American newspapers cited some of the four analysed medical journals about three times a week in 2008–2015 (weekly mean 3.2 and 2.7 citations, respectively); the newspapers from other Western countries did so about once a week (weekly mean 1.1), and those from the Rest of the World cited them about once a month (monthly mean 1.1). The New York Times cited above all other newspapers (weekly mean 4.7). The analysis showed the existence of three national citation patterns in the daily press: American newspapers cited mostly American journals (70.0% of citations), British newspapers cited mostly British journals (86.5%) and the rest of the analysed press cited more British journals than American ones. The Lancet was the most cited journal in the press of almost all Western countries outside the USA and the UK. Multivariate correspondence analysis confirmed the national patterns and showed that over 85% of the citation data variability is retained in just one single new variable: the national dimension. Conclusion: British and American newspapers are the ones that cite the four analysed medical journals more often, showing a domestic preference for their respective national journals; non-British and non-American newspapers show a common international citation pattern., RR and EC belong to MiRoR (Methods in Research on Research), which has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 676207. EC is partially supported by grants MTM2015-64465-C2-1-R (MINECO/FEDER) from the Ministerio de Economía y Competitividad (Spain), and 2014 SGR 464 from the Departament d’Economia i Coneixement de la Generalitat de Catalunya.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

BDNF and cortisol in the diagnosis of cocaine-induced depression

  • Fonseca Casals, Francina, 1972-
  • Mestre-Pintó, Juan Ignacio
  • Rodríguez-Minguela, Rocío
  • Papaseit Fontanet, Esther
  • Pérez Mañá, Clara
  • Langohr, Klaus
  • Barbuti, Margherita
  • Farré Albaladejo, Magí
  • Torrens, Marta
  • Neurodep Group
Background: Major depressive disorder (MDD) and cocaine use disorder (CUD) are related with disability and high mortality rates. The assessment and treatment of psychiatric comorbidity is challenging due to its high prevalence and its clinical severity, mostly due to suicide rates and the presence of medical comorbidities. The aim of this study is to investigate differences in brain derived neurotrophic factor (BDNF) and cortisol plasmatic levels in patients diagnosed with CUD-primary-MDD and CUD-induced-MDD and also to compare them to a sample of MDD patients (without cocaine use), a sample of CUD (without MDD), and a group of healthy controls (HC) after a stress challenge. Methods: A total of 46 subjects were included: MDD (n = 6), CUD (n = 15), CUD-primary-MDD (n = 16), CUD-induced-MDD (n = 9), and 21 HC. Psychiatric comorbidity was assessed with the Spanish version of the Psychiatric Research Interview for Substance and Mental Disorders IV (PRISM-IV), and depression severity was measured with the Hamilton Depression Rating Scale (HDRS). Patients were administered the Trier Social Stress Test (TSST) before and after the biological measures, including BDNF, and cortisol levels were obtained. Results: After the TSST, Cohen's d values between CUD-primary-MDD and CUD-induced-MDD increased in each assessment from 0.19 post-TSST to 2.04 post-90-TSST. Pairwise differences among CUD-induced-MDD and both MDD and HC groups had also a large effect size value in post-30-TSST and post-90-TSST. In the case of the BDNF concentrations, CUD-primary-MDD and CUD-induced-MDD in post-90-TSST (12,627.27 ± 5488.09 vs.17,144.84 ± 6581.06, respectively) had a large effect size (0.77). Conclusion: Results suggest a different pathogenesis for CUD-induced-MDD with higher levels of cortisol and BDNF compared with CUD-primary-MDD. Such variations should imply different approaches in treatment., This work was supported by grants from the Instituto de Salud Carlos III–ISCIII Red de Trastornos Adictivos 2016 (RD16/0017/0010 and RD16/0017/0003); Fondo de Investigación Sanitaria (FIS) (PI09/02121, PI12/01838, PI16/00603); National R + D+I and funded by the Instituto de Salud Carlos III (ISCIII) and the European Regional Development Fund (FEDER) grant Juan Rodes (JR 16/00020); Ministerio de Sanidad, Política Social e Igualdad, Plan Nacional Sobre Drogas (PNSD) (2012I054); Suport Grups de Recerca AGAUR-Gencat (2017 SGR 316, 2017 SGR 530); Ministerio de Economía y Competitividad (MTM2015-64465-C2-1-R); ISCIII-Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS); Red de Investigación en Atención Primaria de Adicciones (RIAPAd), grant number RD21/0009/0001. The funding agencies had no role in study design, data collection, interpretation, and no influence on the writing.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Short- and medium-term impact of bariatric surgery on the activities of CYP2D6, CYP3A4, CYP2C9, and CYP1A2 in morbid obesity

  • Rodríguez-Morató, Jose, 1987-
  • Goday Arnó, Albert
  • Langohr, Klaus
  • Pujadas Bastardes, Mitona
  • Civit, Ester
  • Pérez Mañá, Clara
  • Papaseit Fontanet, Esther
  • Ramon, Jose Manuel
  • Benaiges Foix, David
  • Castañer, Olga
  • Farré Albaladejo, Magí
  • Torre Fornell, Rafael de la
Morbid obesity and bariatric surgery induce anatomical, physiological and metabolic alterations that may alter the body's disposition of drugs. Current literature on this topic is limited and sometimes inconsistent. Cytochrome P450 (CYP) is a superfamily of enzymes that metabolize around 75% of all marketed drugs. The purpose of this study was to evaluate the impact of body mass index and bariatric surgery on CYP activities. Firstly, we evaluated the in vivo activity of 4 major CYP isoenzymes (CYP2D6, CYP3A4, CYP2C9, and CYP1A2) in normal weight, overweight, and morbidly obese individuals. Secondly, we assessed the short- (1 month) and medium-term (6 month) effects of the most commonly employed bariatric surgery techniques (laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass) on the activity of these enzymes. CYP3A4 activity was lower in morbidly obese individuals, compared to normal-weight controls. Interestingly, bariatric surgery normalized CYP3A4 activity. In comparison with normal-weight controls, morbidly obese individuals had higher CYP2D6 activity, which was only observed in individuals with two functional alleles for this isoenzyme. Neither body mass index nor surgery had significant effects on CYP2C9 and CYP1A2 activities. Overall, no relevant differences in CYP activities were found between surgical techniques. In conclusion, further studies should evaluate whether the observed alterations in CYP3A4 activity will require dose adjustments for CYP3A4 substrates especially in morbidly obese individuals before and after bariatric surgery., This work was supported by a grant from the Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias, FISS ETS PI08/90638 co-financed with European Union ERDF funds (European Regional Development Fund). It was also partially supported by grants MTM2015-64465-C2-1-R from the Ministerio de Economía y Competividad (Spain) and 2014 SGR 464 from the Departament d’Economia i Coneixement de la Generalitat de Catalunya (Spain). JRM acknowledges the EU Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant No. 712949 (TECNIOspring PLUS) from the Agency for Business Competitiveness of the Government of Catalonia. OCN and EPF had grants from ISCIII Juan Rodés JR17/00022 and JR 16/00020.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

SVM-RFE: selection and visualization of the most relevant features through non-linear kernels

  • Sanz, Hector
  • Valim, Clarissa
  • Vegas Lozano, Esteban
  • Oller, Josep M.
  • Reverter Comes, Ferran
Background: Support vector machines (SVM) are a powerful tool to analyze data with a number of predictors approximately equal or larger than the number of observations. However, originally, application of SVM to analyze biomedical data was limited because SVM was not designed to evaluate importance of predictor variables. Creating predictor models based on only the most relevant variables is essential in biomedical research. Currently, substantial work has been done to allow assessment of variable importance in SVM models but this work has focused on SVM implemented with linear kernels. The power of SVM as a prediction model is associated with the flexibility generated by use of non-linear kernels. Moreover, SVM has been extended to model survival outcomes. This paper extends the Recursive Feature Elimination (RFE) algorithm by proposing three approaches to rank variables based on non-linear SVM and SVM for survival analysis. Results: The proposed algorithms allows visualization of each one the RFE iterations, and hence, identification of the most relevant predictors of the response variable. Using simulation studies based on time-to-event outcomes and three real datasets, we evaluate the three methods, based on pseudo-samples and kernel principal component analysis, and compare them with the original SVM-RFE algorithm for non-linear kernels. The three algorithms we proposed performed generally better than the gold standard RFE for non-linear kernels, when comparing the truly most relevant variables with the variable ranks produced by each algorithm in simulation studies. Generally, the RFE-pseudo-samples outperformed the other three methods, even when variables were assumed to be correlated in all tested scenarios. Conclusions: The proposed approaches can be implemented with accuracy to select variables and assess direction and strength of associations in analysis of biomedical data using SVM for categorical or time-to-event responses. Conducting variable selection and interpreting direction and strength of associations between predictors and outcomes with the proposed approaches, particularly with the RFE-pseudo-samples approach can be implemented with accuracy when analyzing biomedical data. These approaches, perform better than the classical RFE of Guyon for realistic scenarios about the structure of biomedical data., This work was funded by Grant MTM2015–64465-C2–1-R (MINECO/FEDER) from the Ministerio de Economía y Competitividad (Spain) to JMO and EV. The funding didn’t play any role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The tryptophan system in cocaine-induced depression

  • Fonseca Casals, Francina, 1972-
  • Mestre-Pintó, Juan Ignacio
  • Gómez-Gómez, Àlex
  • Martínez-Sanvisens, Diana
  • Rodríguez-Minguela, Rocío
  • Papaseit Fontanet, Esther
  • Pérez Mañá, Clara
  • Langohr, Klaus
  • Valverde Granados, Olga
  • Pozo Mendoza, Óscar J., 1975-
  • Farré Albaladejo, Magí
  • Pérez Mañá, Clara
  • Neurodep Group
Major depression disorder (MDD) is the most prevalent psychiatric comorbid condition in cocaine use disorder (CUD). The comorbid MDD might be primary-MDD (CUD-primary-MDD) or cocaine-induced MDD (CUD-induced-MDD), and their accurate diagnoses and treatment is a challenge for improving prognoses. This study aimed to assess the tryptophan/serotonin (Trp/5-HT) system with the acute tryptophan depletion test (ATD), and the kynurenine pathway in subjects with CUD-primary-MDD, CUD-induced-MDD, MDD and healthy controls. The ATD was performed with a randomized, double-blind, crossover, and placebo-controlled design. Markers of enzymatic activity of indoleamine 2,3-dioxygenase/tryptophan 2,3-dioxygenase, kynurenine aminotransferase (KAT) and kynureninase were also established. Following ATD, we observed a decrease in Trp levels in all groups. Comparison between CUD-induced-MDD and MDD revealed significant differences in 5-HT plasma concentrations (512 + 332 ng/mL vs. 107 + 127 ng/mL, p = 0.039) and the Kyn/5-HT ratio (11 + 15 vs. 112 + 136; p = 0.012), whereas there were no differences between CUD-primary-MDD and MDD. Effect size coefficients show a gradient for all targeted markers (d range 0.72-1.67). Results suggest different pathogenesis for CUD-induced-MDD, with lower participation of the tryptophan system, probably more related to other neurotransmitter pathways and accordingly suggesting the need for a different pharmacological treatment approach., This work was supported by grants from the Instituto de Salud Carlos III–ISCIII Red de Trastornos Adictivos 2016 (RD16/0017/0010, RD16/0017/0003; Fondo de Investigación Sanitaria (FIS) (PI09/02121, PI12/01838, PI14/00178, PI16/00603); National R + D+I and funded by the Instituto de Salud Carlos III (ISCIII) and the European Regional Development Fund (FEDER) grant Juan Rodes (JR 16/00020); Ministerio de Sanidad, Política Social e Igualdad, Plan Nacional Sobre Drogas (PNSD) (2012I054); Suport Grups de Recerca AGAUR-Gencat (2017 SGR 316, 2017 SGR 530); Acció instrumental d’Intensificació de Professionals de la Salut - Facultatius especialistes (PERIS) (SLT006/17/00014); and Ministerio de Economía y Competitividad (MTM2015-64465-C2-1-R). The funding agencies had no role in study design, data collection, interpretation, or had influence on the writing.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Integrative Multi-omics Analysis to Characterize Human Brain Ischemia

  • Ramiro Pascual, Laura
  • García-Berrocoso, Teresa
  • Briansó, Ferran
  • Goicoechea, Leire
  • Simats, Alba
  • Llombart, Víctor
  • Gonzalo, Ricardo
  • Hainard, Alexandre
  • Martínez-Sáez, Elena
  • Canals, Francesc
  • Sanchez, Jean-Charles
  • Sánchez-Plà, Álex
  • Montaner, Joan
Stroke is a major cause of death and disability. A better comprehension of stroke pathophysiology is fundamental to reduce its dramatic outcome. The use of high-throughput unbiased omics approaches and the integration of these data might deepen the knowledge of stroke at the molecular level, depicting the interaction between different molecular units. We aimed to identify protein and gene expression changes in the human brain after ischemia through an integrative approach to join the information of both omics analyses. The translational potential of our results was explored in a pilot study with blood samples from ischemic stroke patients. Proteomics and transcriptomics discovery studies were performed in human brain samples from six deceased stroke patients, comparing the infarct core with the corresponding contralateral brain region, unveiling 128 proteins and 2716 genes significantly dysregulated after stroke. Integrative bioinformatics analyses joining both datasets exposed canonical pathways altered in the ischemic area, highlighting the most influential molecules. Among the molecules with the highest fold-change, 28 genes and 9 proteins were selected to be validated in five independent human brain samples using orthogonal techniques. Our results were confirmed for NCDN, RAB3C, ST4A1, DNM1L, A1AG1, A1AT, JAM3, VTDB, ANXA1, ANXA2, and IL8. Finally, circulating levels of the validated proteins were explored in ischemic stroke patients. Fluctuations of A1AG1 and A1AT, both up-regulated in the ischemic brain, were detected in blood along the first week after onset. In summary, our results expand the knowledge of ischemic stroke pathology, revealing key molecules to be further explored as biomarkers and/or therapeutic targets. Graphical abstract: [Figure not available: see fulltext.]., This work has been funded by Instituto de Salud Carlos III (PI15/00354, PI18/00804), MINECO (MTM2015-64465-C2-1R) and GRBIO (2014-SGR-464) and co-financed by the European Regional Development Fund (FEDER). Neurovascular Research Laboratory takes part in the Spanish stroke research network INVICTUS + (RD16/0019/0021). L.R is supported by a pre-doctoral fellowship from the Instituto de Salud Carlos III (IFI17/00012)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Obesity status and obesity-associated gut dysbiosis effects on hypothalamic structural covariance

  • Contreras-Rodríguez, Oren
  • Arnoriaga-Rodríguez, María
  • Miranda-Olivos, Romina
  • Blasco, Gerard
  • Biarnés, Carles
  • Puig, Josep
  • Rivera-Pinto, J.
  • Calle, M. L.
  • Pérez-Brocal, Vicente
  • Moya, Andrés
  • Coll, Clàudia
  • Ramió-Torrentà, Lluís
  • Soriano-Mas, C.
  • Fernández-Real, José Manuel
[Background]: Functional connectivity alterations in the lateral and medial hypothalamic networks have been associated with the development and maintenance of obesity, but the possible impact on the structural properties of these networks remains largely unexplored. Also, obesity-related gut dysbiosis may delineate specific hypothalamic alterations within obese conditions. We aim to assess the effects of obesity, and obesity and gut-dysbiosis on the structural covariance differences in hypothalamic networks, executive functioning, and depressive symptoms., [Methods]: Medial (MH) and lateral (LH) hypothalamic structural covariance alterations were identified in 57 subjects with obesity compared to 47 subjects without obesity. Gut dysbiosis in the subjects with obesity was defined by the presence of high (n = 28) and low (n = 29) values in a BMI-associated microbial signature, and posthoc comparisons between these groups were used as a proxy to explore the role of obesity-related gut dysbiosis on the hypothalamic measurements, executive function, and depressive symptoms., [Results]: Structural covariance alterations between the MH and the striatum, lateral prefrontal, cingulate, insula, and temporal cortices are congruent with previously functional connectivity disruptions in obesity conditions. MH structural covariance decreases encompassed postcentral parietal cortices in the subjects with obesity and gut-dysbiosis, but increases with subcortical nuclei involved in the coding food-related hedonic information in the subjects with obesity without gut-dysbiosis. Alterations for the structural covariance of the LH in the subjects with obesity and gut-dysbiosis encompassed increases with frontolimbic networks, but decreases with the lateral orbitofrontal cortex in the subjects with obesity without gut-dysbiosis. Subjects with obesity and gut dysbiosis showed higher executive dysfunction and depressive symptoms., [Conclusions]: Obesity-related gut dysbiosis is linked to specific structural covariance alterations in hypothalamic networks relevant to the integration of somatic-visceral information, and emotion regulation., This study has been funded by the Project Grant IRONMET (PI15/01934) from the ISCIII, and the Project ThinkGut (EFA345/19) 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A Spain-France-Andorra program (POCTEFA 2014–2020) (JM Fernández-Real). Partial support was also obtained by the Ministerio de Economia y Competitividad, Spain, reference MTM2015-64465-C2-1-R (ML Calle). O Contreras-Rodriguez is funded by a “PERIS” postdoctoral fellowship (SLT006/17/00236) from the Health Department of the Catalan Government and by a “Miguel Servet” contract (CP20/00165) from the ISCIII. M Arnoriaga-Rodríguez is funded by a predoctoral Rio Hortega contract (CM19/00190) co-funded by European Social Fund “Investigating in your future” from the ISCIII., Peer reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Incidence of injuries in competition of Leonese wrestling and associated factors (2005–2015) Incidencia de lesiones en la competición de Lucha Leonesa y Factores Asociados (2005-2015)

  • Martín Sánchez, Vicente
  • Blasco, María J.
  • Casals Toquero, Martí
  • Langohr, Klaus|||0000-0001-7075-9192
© 2018. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/, Introducción: La lucha tradicional es considerada un patrimonio cultural de la humanidad que debe protegerse. El estudio de las lesiones y sus factores asociados puede favorecer la protección de este patrimonio. El presente estudio pretende analizar la incidencia de las lesiones y sus factores asociados en la competición de una modalidad de lucha tradicional: la Lucha Leonesa (LL). Material y métodos: Estudio observacional, prospectivo y de cohorte, que recolectó las lesiones ocurridas durante las competiciones de verano entre 2005 y 2015. La incidencia de lesiones fue calculada por cada 1000 atletas/expuestos (AEs), en función de la edad de iniciación a la LL, edad en el momento de la competición, regularidad de los participantes en la competición, perfil ganador y categoría de peso. Se utilizó un análisis multivariante mediante un modelo mixto lineal generalizado, asumiendo que las lesiones seguían una distribución de Poisson. Resultados: Se registraron 308 luchadores y 406 lesiones en 31.970 AEs. La incidencia de lesiones por cada 1000 AEs fue de 3 lesiones (graves), 6,7 (moderadas y graves) y 12,7 (en el total de lesiones registradas). Se observó una mayor incidencia en aquellos luchadores: no regulares (IRR = 1,076; IC: 0,846-1,368), con perfil no ganador y los que se iniciaron en la lucha de adolescentes (IRR = 1,115; IC: 0,856-1,452). Los luchadores con perfil no ganador tuvieron un mayor riesgo de lesiones en las categorías de semipesados y pesados. Conclusiones: La incidencia de lesiones en la LL es consistente con la incidencia esperada en otros deportes de contacto. La ausencia de regularidad a la hora de competir, haberse iniciado tarde en la lucha, mostrar un perfil no ganador y competir en la categoría de los pesos pesados, son factores que se asocian al riesgo de presentar una lesión en sus practicantes, Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Mortality of NBA Players: risk factors and comparison with the general US population

  • Martínez García, Jose Antonio
  • Langohr, Klaus|||0000-0001-7075-9192
  • Felipo, Julián
  • Casals Toquero, Martí
Concerns have been raised recently by players’ associations regarding the risk of death among retired players. Using a retrospective cohort study, we analyzed factors associated with the mortality of National Basketball Association (NBA) players and compared their life expectancy with that of the general population. We analyzed a cohort of 3985 players who participated in the NBA from its inception in 1946 to April 2015 (481 active and 3504 former players). We used the data for the 3504 former NBA players, of whom 687 (19.1%) died before 15 April 2015, to study the elapsed time between the end of their NBA careers until death. Cox proportional hazards models were employed in the multivariate survival analysis. After adjusting for age at the end of the NBA career and calendar year, we found that mortality is associated with height and ethnicity. Taller players and African-American players had a higher instantaneous risk of death than shorter players or white players. In addition, the life expectancy of players (regardless of height and ethnicity) has increased since the inception of the NBA. This is one of the first studies using such an extensive cohort of professional basketball players and Cox proportional hazards models. Results confirmed that height is associated with mortality. In addition, ethnicity is also linked to mortality; white players and small players live longer. Our study is useful for devising strategies for health interventions and the proper allocation of resources with respect to the general population., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Balances: a new perspective for microbiome analysis

  • Rivera Pinto, J.
  • Egozcue Rubí, Juan José|||0000-0002-5144-4483
  • Pawlowsky Glahn, Vera
  • Paredes, Raul
  • Noguera Julian, Marc
  • Calle, M. L.
High-throughput sequencing technologies have revolutionized microbiome research by allowing the relative quantification of microbiome composition and function in different environments. In this work we focus on the identification of microbial signatures, groups of microbial taxa that are predictive of a phenotype of interest. We do this by acknowledging the compositional nature of the microbiome and the fact that it carries relative information. Thus, instead of defining a microbial signature as a linear combination in real space corresponding to the abundances of a group of taxa, we consider microbial signatures given by the geometric means of data from two groups of taxa whose relative abundances, or balance, are associated with the response variable of interest. In this work we present selbal, a greedy stepwise algorithm for selection of balances or microbial signatures that preserves the principles of compositional data analysis. We illustrate the algorithm with 16S rRNA abundance data from a Crohn’s microbiome study and an HIV microbiome study. We propose a new algorithm for the identification of microbial signatures. These microbial signatures can be used for diagnosis, prognosis, or prediction of therapeutic response based on an individual’s specific microbiota., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Non-constant hazard ratios in randomized controlled trials with composite endpoints

  • Cortés Martínez, Jordi|||0000-0002-3764-0795
  • Gómez Mateu, Moisès
  • Kim, Kyungman
  • Gómez Melis, Guadalupe|||0000-0003-4252-4884
The hazard ratio is routinely used as a summary measure to assess the treatment effect in clinical trials with time-to-event endpoints. It is frequently assumed as constant over time although this assumption often does not hold. When the hazard ratio deviates considerably from being constant, the average of its plausible values is not a valid measure of the treatment effect, can be clinically misleading and common sample size formulas are not appropriate. In this paper, we study the hazard ratio along time of a two-component composite endpoint under the assumption that the hazard ratio for each component is constant. This work considers two measures for quantifying the non-proportionality of the hazard ratio: the difference D between the maximum and minimum values of hazard ratio over time and the relative measure R representing the ratio between the sample sizes for the minimum detectable and the average effects. We illustrate D and R by means of the ZODIAC trial where the primary endpoint was progression-free survival. We have run a simulation study deriving scenarios for different values of the hazard ratios, different event rates and different degrees of association between the components. We illustrate situations that yield non-constant hazard ratios for the composite endpoints and consider the likely impact on sample size. Results show that the distance between the two component hazard ratios plays an important role, especially when they are close to 1. Furthermore, even when the treatment effects for each component are similar, if the two-component hazards are markedly different, hazard ratio of the composite is often non-constant., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Modeling the coronavirus disease 2019 incubation period: impact on quarantine policy

  • Pak, Daewoo
  • Langohr, Klaus|||0000-0001-7075-9192
  • Ning, Jing
  • Cortés Martínez, Jordi|||0000-0002-3764-0795
  • Gómez Melis, Guadalupe|||0000-0003-4252-4884
  • Shen, Yu
The incubation period of coronavirus disease 2019 (COVID-19) is not always observed exactly due to uncertain onset times of infection and disease symptoms. In this paper, we demonstrate how to estimate the distribution of incubation and its association with patient demographic factors when the exact dates of infection and symptoms’ onset may not be observed. The findings from analysis of the confirmed COVID-19 cases indicate that age could be associated with the incubation period, and an age-specific quarantine policy might be more efficient than a unified one in confining COVID-19., This research was funded by the Ministerio de Ciencia e Innovación (Spain) (PID2019-104830RB-I00),the Ministerio de Economía y Competitividad (Spain) (MTM2015-64465-C2-1-R (MINECO/FEDER)), and theDepartament d’Economia i Coneixement de la Generalitat de Catalunya (Spain) (2017 SGR 622 (GRBIO))., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

A systematic review of sport-related packages within the R CRAN repository

  • Casals Toquero, Martí
  • Fernández, Jose
  • Martínez Rech, Víctor
  • López, Michael
  • Langohr, Klaus|||0000-0001-7075-9192
  • Cortés Martínez, Jordi|||0000-0002-3764-0795
© The Author(s) 2022, The sports statistics community is rapidly evolving. R is an open-source software in constant development that has gained a lot of popularity within statistical communities and sports analytics. This work presents a systematic review of the available R CRAN sport packages following PRISMA guidelines. We consider all packages active as of 18 February 2021. A total of 81 sport R packages created since 2006 were detected. Of these, 35.9% were authored by an American national, 69.1% include a dataset, 43.2% provide vignettes, and 65.4% have been updated at least once. The sport with the highest representation is basketball (n¿=¿14, 17.3%), followed by soccer (n¿=¿12, 14.8%) and packages related to physical activity (n¿=¿11, 13.6%). There are no sports packages directed solely for the female gender, while 59.3% of packages are focused on professional athletes. Fifty packages (61.7%) are related to the sports performance analysis category, and web scraping (n¿=¿43, 53.1%) was the main functionality in the collected packages. The creation of new R packages in the area of sports could help solve questions and tasks that still remain a challenge in this field, while continuing to help to improve the level of statistical education and computational thinking skills., The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was funded by the Ministerio de Ciencia e Innovación (Spain) (PID2019-104830RB-I00) and the Departament d’Economia i Coneixement de la Generalitat de Catalunya (Spain) (2017 SGR 622 (GRBIO))., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

SARS-Cov-2 incubation period according to vaccination status during the fifth COVID-19 wave in a tertiary-care center in Spain: a cohort study

  • Cortés Martínez, Jordi|||0000-0002-3764-0795
  • Pak, Daewoo
  • Abelenda Alonso, Gabriela
  • Langohr, Klaus|||0000-0001-7075-9192
  • Ning, Jing
  • Rombauts, Alexander
  • Colom Guerra, Mireia
  • Shen, Yu
  • Gómez Melis, Guadalupe|||0000-0003-4252-4884
Background: The incubation period of an infectious disease is defined as the elapsed time between the exposure to the pathogen and the onset of symptoms. Although both the mRNA-based and the adenoviral vector-based vaccines have shown to be effective, there have been raising concerns regarding possible decreases in vaccine effectiveness for new variants and variations in the incubation period. Methods: We conducted a unicentric observational study at the Hospital Universitari de Bellvitge, Barcelona, using a structured telephone survey performed by trained interviewers to estimate the incubation period of the SARS-CoV-2 Delta variant in a cohort of Spanish hospitalized patients. The distribution of the incubation period was estimated using the generalized odds-rate class of regression models. Results: From 406 surveyed patients, 242 provided adequate information to be included in the analysis. The median incubation period was 2.8 days (95%CI: 2.5–3.1) and no differences between vaccinated and unvaccinated patients were found. Sex and age are neither shown not to be significantly related to the COVID-19 incubation time. Conclusions: Knowing the incubation period is crucial for controlling the spread of an infectious disease: decisions on the duration of the quarantine or on the periods of active monitoring of people who have been at high risk of exposure depend on the length of the incubation period. Furthermore, its probability distribution is a key element for predicting the prevalence and the incidence of the disease., This research was funded by the Ministerio de Ciencia e Innovación (Spain) [PID2019-104830RB-I00/ DOI (AEI): https://doi.org/10.13039/5011000110 33], by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) de la Generalitat de Catalunya (2020PANDE00148), by grant [2017SGR622] (GRBIO) administrated by the Departament d’Economia i Coneixement de la Gener‑ alitat de Catalunya (Spain), and by the National Research Foundation of Korea (2021R1G1A1009269)., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

An iterative method to protect the type I error rate in bioequivalence studies under two-stage adaptive 2×2 crossover designs

  • Molins Lleonart, Eduard
  • Labes, Detlew
  • Schütz, Helmut
  • Cobo Valeri, Erik|||0000-0002-3534-5602
  • Ocaña Rebull, Jordi|||0000-0002-4736-6996
This is the peer reviewed version of the following article: Molins, E. [et al.]. An iterative method to protect the type I error rate in bioequivalence studies under two-stage adaptive 2×2 crossover designs. "Biometrical journal", 2021, vol. 63, núm. 1, p. 122-133., which has been published in final form at https://onlinelibrary.wiley.com/doi/10.1002/bimj.201900388. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving., Bioequivalence studies are the pivotal clinical trials submitted to regulatory agen- cies to support the marketing applications of generic drug products. Average bioequivalence (ABE) is used to determine whether the mean values for the pharmacokinetic measures determined after administration of the test and refer- ence products are comparable. Two-stage 2×2 crossover adaptive designs (TSDs) are becoming increasingly popular because they allow making assumptions on the clinically meaningful treatment effect and a reliable guess for the unknown within-subject variability. At an interim look, if ABE is not declared with an ini- tial sample size, they allow to increase it depending on the estimated variability and to enroll additional subjects at a second stage, or to stop for futility in case of poor likelihood of bioequivalence. This is crucial because both parameters must clearly be prespecified in protocols, and the strategy agreed with regulatory agen- cies in advance with emphasis on controlling the overall type I error. We present an iterative method to adjust the significance levels at each stage which preserves the overall type I error for a wide set of scenarios which should include the true unknown variability value. Simulations showed adjusted signif- icance levels higher than 0.0300 in most cases with type I error always below 5%, and with a power of at least 80%. TSDs work particularly well for coefficients of variation below 0.3 which are especially useful due to the balance between the power and the percentage of studies proceeding to stage 2. Our approach might support discussions with regulatory agencies., This research is partially supported by the grant MTM2015-64465-C2-1-R (MINECO/FEDER) from the Ministerio de Economia y Competitividad (Spain) and by the grant 2014 SGR 464 from the Generalitat de Catalunya., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Contribución de congreso (ConferenceOutput)

Using simulation and reliability concepts to set starting times in multitask projects with a common deadline

  • Juan Pérez, Ángel Alejandro
  • Calvet Liñán, Laura
  • Serrat Piè, Carles|||0000-0002-1504-5354
  • Hatami, Sara|||0000-0002-8000-4989
In production and transportation logistics, it is frequent to have projects in which different tasks must be processed in parallel and completed before a common deadline. Usually, it is not desirable to assign scarce resources to a new project earlier than strictly necessary, since they might be currently occupied in other projects. When these tasks have random completion times, some natural questions arise: (i) how much can we delay the starting time of each task in the new project so that it can be completed by the deadline with a given probability? and (ii) how to compute these ‘optimal’ starting times when not all tasks need to be necessarily finished to consider the project as completed? This paper proposes a hybrid approach, combining reliability concepts with simulation and optimization techniques, to support decision makers in finding the optimal starting times for each task under the described uncertainty scenario., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

A new approach for sizing trials with composite binary endpoints using anticipated marginal values and accounting for the correlation between components

  • Bofill Roig, Marta|||0000-0002-4400-7541
  • Gómez Melis, Guadalupe|||0000-0003-4252-4884
This is the peer reviewed version of the following article: Bofill, M.; Gómez Melis, G. A new approach for sizing trials with composite binary endpoints using anticipated marginal values and accounting for the correlation between components. "Statistics in medicine", 20 Maig 2019, vol. 38, núm. 11, p. 1935-1956, which has been published in final form at https://doi.org/10.1002/sim.8092. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving., Composite binary endpoints are increasingly used as primary endpoints in clinical trials. When designing a trial, it is crucial to determine the appropriate sample size for testing the statistical differences between treatment groups for the primary endpoint. As shown in this work, when using a composite binary endpoint to size a trial, one needs to specify the event rates and the effect sizes of the composite components as well as the correlation between them. In practice, the marginal parameters of the components can be obtained from previous studies or pilot trials; however, the correlation is often not previously reported and thus usually unknown. We first show that the sample size for composite binary endpoints is strongly dependent on the correlation and, second, that slight deviations in the prior information on the marginal parameters may result in underpowered trials for achieving the study objectives at a pre-specified significance level. We propose a general strategy for calculating the required sample size when the correlation is not specified and accounting for uncertainty in the marginal parameter values. We present the web platform CompARE to characterize composite endpoints and to calculate the sample size just as we propose in this paper. We evaluate the performance of the proposal with a simulation study and illustrate it by means of a real case study using CompARE., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Using the geometric average hazard ratio in sample size calculation for time-to-event data with composite endpoints

  • Cortés Martínez, Jordi|||0000-0002-3764-0795
  • Geskus, Ronald
  • Kim, Kyungman
  • Gómez Melis, Guadalupe|||0000-0003-4252-4884
Background: Sample size calculation is a key point in the design of a randomized controlled trial. With time-to-event outcomes, it’s often based on the logrank test. We provide a sample size calculation method for a composite endpoint (CE) based on the geometric average hazard ratio (gAHR) in case the proportional hazards assumption can be assumed to hold for the components, but not for the CE. Methods: The required number of events, sample size and power formulae are based on the non-centrality parameter of the logrank test under the alternative hypothesis which is a function of the gAHR. We use the web platform, CompARE, for the sample size computations. A simulation study evaluates the empirical power of the logrank test for the CE based on the sample size in terms of the gAHR. We consider different values of the component hazard ratios, the probabilities of observing the events in the control group and the degrees of association between the components. We illustrate the sample size computations using two published randomized controlled trials. Their primary CEs are, respectively, progression-free survival (time to progression of disease or death) and the composite of bacteriologically confirmed treatment failure or Staphylococcus aureus related death by 12 weeks. Results: For a target power of 0.80, the simulation study provided mean (± SE) empirical powers equal to 0.799 (±0.004) and 0.798 (±0.004) in the exponential and non-exponential settings, respectively. The power was attained in more than 95% of the simulated scenarios and was always above 0.78, regardless of compliance with the proportional-hazard assumption. Conclusions: The geometric average hazard ratio as an effect measure for a composite endpoint has a meaningful interpretation in the case of non-proportional hazards. Furthermore it is the natural effect measure when using the logrank test to compare the hazard rates of two groups and should be used instead of the standard hazard ratio., G. G´omez and J. Cort´es were partially supported by the Ministerio de Econom´ıa y Competitividad (Spain) [MTM2015-64465-C2-1-R (MINECO/FEDER)], the Ministerio de Ciencia, innovaci´on y Universidades [PID2019-104830RB-I00] and the Departament d’Economia i Coneixement de la Generalitat de Catalunya (Spain)[2017 SGR 622 (GRBIO)]. Ronald B. Geskus was supported by the Wellcome Trust (grant number 106680/Z/14/Z)., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Two-stage designs versus European scaled average designs in bioequivalence studies for highly variable drugs: which to choose?

  • Molins Lleonart, Eduard
  • Cobo Valeri, Erik|||0000-0002-3534-5602
  • Ocaña Rebull, Jordi|||0000-0002-4736-6996
This is the peer reviewed version of the following article: Molins, E., Cobo, E., Ocaña, J. Two-stage designs versus European scaled average designs in bioequivalence studies for highly variable drugs: which to choose?. "Statistics in medicine", Desembre 2017, vol. 36, núm. 30, p. 4777-4788, which has been published in final form at http://onlinelibrary.wiley.com/doi/10.1002/sim.7452/pdf. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving., The usual approach to determine bioequivalence for highly variable drugs is scaled average bioequivalence, which is based on expanding the limits as a function of the within-subject variability in the reference formulation. This requires separately estimating this variability and thus using replicated or semireplicated crossover designs. On the other hand, regulations also allow using common 2 × 2 crossover designs based on two-stage adaptive approaches with sample size reestimation at an interim analysis. The choice between scaled or two-stage designs is crucial and must be fully described in the protocol. Using Monte Carlo simulations, we show that both methodologies achieve comparable statistical power, though the scaled method usually requires less sample size, but at the expense of each subject being exposed more times to the treatments. With an adequate initial sample size (not too low, eg, 24 subjects), two-stage methods are a flexible and efficient option to consider: They have enough power (eg, 80%) at the first stage for non-highly variable drugs, and, if otherwise, they provide the opportunity to step up to a second stage that includes additional subjects., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Contribución de congreso (ConferenceOutput)

A vector scale of severity of damages in buildings

  • Ruiz Gorrindo, Félix
  • Aguado de Cea, Antonio|||0000-0001-5542-6365
  • Serrat Piè, Carles|||0000-0002-1504-5354
In the context of the existing buildings, along the recent years the concept of maintenance has changed from corrective maintenance to preventive maintenance, which is based in part on periodic inspections. There is ample evidence that preventive maintenance is more efficient than corrective maintenance, since severe deteriorations that may represent danger to people are avoided, and also money is saved. To make periodic inspections of the buildings is useful to quantify the extent to which deficiencies are severe or not, in order to facilitate decision making and prioritize therapeutic interventions. To this purpose many scales have been used and are used to assess the degree of gravity of the damages in constructive elements. But it is important to say that there is no common consensus and these scales are different between them according to the study to which they belong. Thus, the main goal of this article is to propose a methodology for calculating the degree of severity of damages in buildings, which is of widespread use. This calculation method, which is in distribution and in scalar, lets to calculate the severity index of systems and of the entire building, and it is easy to use and flexible., This research has been partially supported by grants MTM2015-64465-C2-1-R (MINECO / FEDER) from the Ministerio de Economía y Competitividad (Spain) and 2017 SGR 622 from the Departament d’Economia i Coneixement de la Generalitat de Catalunya. Authors are grateful to members of the IEMAE, LABEDI and GRASS-GRBIO groups their valuable comments and suggestions in the development of the work., Objectius de Desenvolupament Sostenible::11 - Ciutats i Comunitats Sostenibles
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

BDNF and cortisol in the diagnosis of cocaine-induced depression

  • Fonseca, Francina
  • Mestre Pintó, Joan
  • Papaseit, Esther
  • Perez Maña, Clara
  • Langohr, Klaus|||0000-0001-7075-9192
  • Farré, Magí
  • Torrens, Marta
Copyright © 2022 Fonseca, Mestre-Pinto, Rodríguez-Minguela, Papaseit, PérezMañá, Langohr, Barbuti, Farré, Torrens andNEURODEP GROUP. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms., Major depressive disorder (MDD) and cocaine use disorder (CUD) are related with disability and high mortality rates. The assessment and treatment of psychiatric comorbidity is challenging due to its high prevalence and its clinical severity, mostly due to suicide rates and the presence of medical comorbidities. The aim of this study is to investigate differences in brain derived neurotrophic factor (BDNF) and cortisol plasmatic levels in patients diagnosed with CUD-primary-MDD and CUD-induced-MDD and also to compare them to a sample of MDD patients (without cocaine use), a sample of CUD (without MDD), and a group of healthy controls (HC) after a stress challenge., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Decision tool and Sample Size Calculator for composite endpoints

  • Bofill Roig, Marta|||0000-0002-4400-7541
  • Cortés Martínez, Jordi|||0000-0002-3764-0795
  • Gómez Melis, Guadalupe|||0000-0003-4252-4884
This article considers the combination of two binary or two time-to-event endpoints to form the primary composite endpoint for leading a trial. • It discusses the relative efficiency of choosing a composite endpoint over one of its components in terms of: the frequencies of observing each component; the relative treatment effect of the tested therapy; and the association between both components. • We highlight the very important role of the association between components in choosing the most efficient endpoint to use as primary. • For better grounded future trials, we recommend trialists to always reporting the association between components of the composite endpoint • Common fallacies to note when using composite endpoints: i) composite endpoints always imply higher power; ii) treatment effect on the composite endpoint is similar to the average effects of its components; and iii) the probability of observing the primary endpoint increases significantly., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

BDNF and cortisol in the diagnosis of cocaine-induced depression

  • Fonseca, Francina
  • Mestre Pintó, Joan
  • Papaseit, Esther
  • Perez Maña, Clara
  • Langohr, Klaus
  • Farré, Magí
  • Torrens, Marta
Copyright © 2022 Fonseca, Mestre-Pinto, Rodríguez-Minguela, Papaseit, PérezMañá, Langohr, Barbuti, Farré, Torrens andNEURODEP GROUP. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms., Major depressive disorder (MDD) and cocaine use disorder (CUD) are related with disability and high mortality rates. The assessment and treatment of psychiatric comorbidity is challenging due to its high prevalence and its clinical severity, mostly due to suicide rates and the presence of medical comorbidities. The aim of this study is to investigate differences in brain derived neurotrophic factor (BDNF) and cortisol plasmatic levels in patients diagnosed with CUD-primary-MDD and CUD-induced-MDD and also to compare them to a sample of MDD patients (without cocaine use), a sample of CUD (without MDD), and a group of healthy controls (HC) after a stress challenge., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

Using simulation and reliability concepts to set starting times in multitask projects with a common deadline

  • Juan Pérez, Ángel Alejandro
  • Calvet Liñán, Laura
  • Serrat Piè, Carles
  • Hatami, Sara
In production and transportation logistics, it is frequent to have projects in which different tasks must be processed in parallel and completed before a common deadline. Usually, it is not desirable to assign scarce resources to a new project earlier than strictly necessary, since they might be currently occupied in other projects. When these tasks have random completion times, some natural questions arise: (i) how much can we delay the starting time of each task in the new project so that it can be completed by the deadline with a given probability? and (ii) how to compute these ‘optimal’ starting times when not all tasks need to be necessarily finished to consider the project as completed? This paper proposes a hybrid approach, combining reliability concepts with simulation and optimization techniques, to support decision makers in finding the optimal starting times for each task under the described uncertainty scenario., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Incidence of injuries in competition of Leonese wrestling and associated factors (2005–2015) Incidencia de lesiones en la competición de Lucha Leonesa y Factores Asociados (2005-2015)

  • Martín Sánchez, Vicente
  • Blasco, María J.
  • Casals Toquero, Martí
  • Langohr, Klaus
© 2018. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/, Introducción: La lucha tradicional es considerada un patrimonio cultural de la humanidad que debe protegerse. El estudio de las lesiones y sus factores asociados puede favorecer la protección de este patrimonio. El presente estudio pretende analizar la incidencia de las lesiones y sus factores asociados en la competición de una modalidad de lucha tradicional: la Lucha Leonesa (LL). Material y métodos: Estudio observacional, prospectivo y de cohorte, que recolectó las lesiones ocurridas durante las competiciones de verano entre 2005 y 2015. La incidencia de lesiones fue calculada por cada 1000 atletas/expuestos (AEs), en función de la edad de iniciación a la LL, edad en el momento de la competición, regularidad de los participantes en la competición, perfil ganador y categoría de peso. Se utilizó un análisis multivariante mediante un modelo mixto lineal generalizado, asumiendo que las lesiones seguían una distribución de Poisson. Resultados: Se registraron 308 luchadores y 406 lesiones en 31.970 AEs. La incidencia de lesiones por cada 1000 AEs fue de 3 lesiones (graves), 6,7 (moderadas y graves) y 12,7 (en el total de lesiones registradas). Se observó una mayor incidencia en aquellos luchadores: no regulares (IRR = 1,076; IC: 0,846-1,368), con perfil no ganador y los que se iniciaron en la lucha de adolescentes (IRR = 1,115; IC: 0,856-1,452). Los luchadores con perfil no ganador tuvieron un mayor riesgo de lesiones en las categorías de semipesados y pesados. Conclusiones: La incidencia de lesiones en la LL es consistente con la incidencia esperada en otros deportes de contacto. La ausencia de regularidad a la hora de competir, haberse iniciado tarde en la lucha, mostrar un perfil no ganador y competir en la categoría de los pesos pesados, son factores que se asocian al riesgo de presentar una lesión en sus practicantes, Peer Reviewed, Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Non-constant hazard ratios in randomized controlled trials with composite endpoints

  • Cortés Martínez, Jordi
  • Gómez Mateu, Moisès
  • Kim, Kyungman
  • Gómez Melis, Guadalupe
The hazard ratio is routinely used as a summary measure to assess the treatment effect in clinical trials with time-to-event endpoints. It is frequently assumed as constant over time although this assumption often does not hold. When the hazard ratio deviates considerably from being constant, the average of its plausible values is not a valid measure of the treatment effect, can be clinically misleading and common sample size formulas are not appropriate. In this paper, we study the hazard ratio along time of a two-component composite endpoint under the assumption that the hazard ratio for each component is constant. This work considers two measures for quantifying the non-proportionality of the hazard ratio: the difference D between the maximum and minimum values of hazard ratio over time and the relative measure R representing the ratio between the sample sizes for the minimum detectable and the average effects. We illustrate D and R by means of the ZODIAC trial where the primary endpoint was progression-free survival. We have run a simulation study deriving scenarios for different values of the hazard ratios, different event rates and different degrees of association between the components. We illustrate situations that yield non-constant hazard ratios for the composite endpoints and consider the likely impact on sample size. Results show that the distance between the two component hazard ratios plays an important role, especially when they are close to 1. Furthermore, even when the treatment effects for each component are similar, if the two-component hazards are markedly different, hazard ratio of the composite is often non-constant., Peer Reviewed, Preprint
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

SVM-RFE: selection and visualization of the most relevant features through non-linear kernels

  • Sanz, Hector
  • Valim, Clarissa
  • Vegas Lozano, Esteban
  • Oller, Josep M.
  • Reverter Comes, Ferran
Background: Support vector machines (SVM) are a powerful tool to analyze data with a number of predictors approximately equal or larger than the number of observations. However, originally, application of SVM to analyze biomedical data was limited because SVM was not designed to evaluate importance of predictor variables. Creating predictor models based on only the most relevant variables is essential in biomedical research. Currently, substantial work has been done to allow assessment of variable importance in SVM models but this work has focused on SVM implemented with linear kernels. The power of SVM as a prediction model is associated with the flexibility generated by use of non-linear kernels. Moreover, SVM has been extended to model survival outcomes. This paper extends the Recursive Feature Elimination (RFE) algorithm by proposing three approaches to rank variables based on non-linear SVM and SVM for survival analysis. Results: The proposed algorithms allows visualization of each one the RFE iterations, and hence, identification of the most relevant predictors of the response variable. Using simulation studies based on time-to-event outcomes and three real datasets, we evaluate the three methods, based on pseudo-samples and kernel principal component analysis, and compare them with the original SVM-RFE algorithm for non-linear kernels. The three algorithms we proposed performed generally better than the gold standard RFE for non-linear kernels, when comparing the truly most relevant variables with the variable ranks produced by each algorithm in simulation studies. Generally, the RFE-pseudo-samples outperformed the other three methods, even when variables were assumed to be correlated in all tested scenarios. Conclusions: The proposed approaches can be implemented with accuracy to select variables and assess direction and strength of associations in analysis of biomedical data using SVM for categorical or time-to-event responses. Conducting variable selection and interpreting direction and strength of associations between predictors and outcomes with the proposed approaches, particularly with the RFE-pseudo-samples approach can be implemented with accuracy when analyzing biomedical data. These approaches, perform better than the classical RFE of Guyon for realistic scenarios about the structure of biomedical data., This work was funded by Grant MTM2015–64465-C2–1-R (MINECO/FEDER) from the Ministerio de Economía y Competitividad (Spain) to JMO and EV. The funding didn’t play any role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Using the geometric average hazard ratio in sample size calculation for time-to-event data with composite endpoints

  • Cortés Martínez, Jordi
  • Geskus, Ronald
  • Kim, Kyungman
  • Gómez Melis, Guadalupe
Background: Sample size calculation is a key point in the design of a randomized controlled trial. With time-to-event outcomes, it’s often based on the logrank test. We provide a sample size calculation method for a composite endpoint (CE) based on the geometric average hazard ratio (gAHR) in case the proportional hazards assumption can be assumed to hold for the components, but not for the CE. Methods: The required number of events, sample size and power formulae are based on the non-centrality parameter of the logrank test under the alternative hypothesis which is a function of the gAHR. We use the web platform, CompARE, for the sample size computations. A simulation study evaluates the empirical power of the logrank test for the CE based on the sample size in terms of the gAHR. We consider different values of the component hazard ratios, the probabilities of observing the events in the control group and the degrees of association between the components. We illustrate the sample size computations using two published randomized controlled trials. Their primary CEs are, respectively, progression-free survival (time to progression of disease or death) and the composite of bacteriologically confirmed treatment failure or Staphylococcus aureus related death by 12 weeks. Results: For a target power of 0.80, the simulation study provided mean (± SE) empirical powers equal to 0.799 (±0.004) and 0.798 (±0.004) in the exponential and non-exponential settings, respectively. The power was attained in more than 95% of the simulated scenarios and was always above 0.78, regardless of compliance with the proportional-hazard assumption. Conclusions: The geometric average hazard ratio as an effect measure for a composite endpoint has a meaningful interpretation in the case of non-proportional hazards. Furthermore it is the natural effect measure when using the logrank test to compare the hazard rates of two groups and should be used instead of the standard hazard ratio., G. G´omez and J. Cort´es were partially supported by the Ministerio de Econom´ıa y Competitividad (Spain) [MTM2015-64465-C2-1-R (MINECO/FEDER)], the Ministerio de Ciencia, innovaci´on y Universidades [PID2019-104830RB-I00] and the Departament d’Economia i Coneixement de la Generalitat de Catalunya (Spain)[2017 SGR 622 (GRBIO)]. Ronald B. Geskus was supported by the Wellcome Trust (grant number 106680/Z/14/Z)., Peer Reviewed, Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

SARS-Cov-2 incubation period according to vaccination status during the fifth COVID-19 wave in a tertiary-care center in Spain: a cohort study

  • Cortés Martínez, Jordi
  • Pak, Daewoo
  • Abelenda Alonso, Gabriela
  • Langohr, Klaus
  • Ning, Jing
  • Rombauts, Alexander
  • Colom Guerra, Mireia
  • Shen, Yu
  • Gómez Melis, Guadalupe
Background: The incubation period of an infectious disease is defined as the elapsed time between the exposure to the pathogen and the onset of symptoms. Although both the mRNA-based and the adenoviral vector-based vaccines have shown to be effective, there have been raising concerns regarding possible decreases in vaccine effectiveness for new variants and variations in the incubation period. Methods: We conducted a unicentric observational study at the Hospital Universitari de Bellvitge, Barcelona, using a structured telephone survey performed by trained interviewers to estimate the incubation period of the SARS-CoV-2 Delta variant in a cohort of Spanish hospitalized patients. The distribution of the incubation period was estimated using the generalized odds-rate class of regression models. Results: From 406 surveyed patients, 242 provided adequate information to be included in the analysis. The median incubation period was 2.8 days (95%CI: 2.5–3.1) and no differences between vaccinated and unvaccinated patients were found. Sex and age are neither shown not to be significantly related to the COVID-19 incubation time. Conclusions: Knowing the incubation period is crucial for controlling the spread of an infectious disease: decisions on the duration of the quarantine or on the periods of active monitoring of people who have been at high risk of exposure depend on the length of the incubation period. Furthermore, its probability distribution is a key element for predicting the prevalence and the incidence of the disease., This research was funded by the Ministerio de Ciencia e Innovación (Spain) [PID2019-104830RB-I00/ DOI (AEI): https://doi.org/10.13039/5011000110 33], by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) de la Generalitat de Catalunya (2020PANDE00148), by grant [2017SGR622] (GRBIO) administrated by the Departament d’Economia i Coneixement de la Gener‑ alitat de Catalunya (Spain), and by the National Research Foundation of Korea (2021R1G1A1009269)., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A new approach for sizing trials with composite binary endpoints using anticipated marginal values and accounting for the correlation between components

  • Bofill Roig, Marta
  • Gómez Melis, Guadalupe
This is the peer reviewed version of the following article: Bofill, M.; Gómez Melis, G. A new approach for sizing trials with composite binary endpoints using anticipated marginal values and accounting for the correlation between components. "Statistics in medicine", 20 Maig 2019, vol. 38, núm. 11, p. 1935-1956, which has been published in final form at https://doi.org/10.1002/sim.8092. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving., Composite binary endpoints are increasingly used as primary endpoints in clinical trials. When designing a trial, it is crucial to determine the appropriate sample size for testing the statistical differences between treatment groups for the primary endpoint. As shown in this work, when using a composite binary endpoint to size a trial, one needs to specify the event rates and the effect sizes of the composite components as well as the correlation between them. In practice, the marginal parameters of the components can be obtained from previous studies or pilot trials; however, the correlation is often not previously reported and thus usually unknown. We first show that the sample size for composite binary endpoints is strongly dependent on the correlation and, second, that slight deviations in the prior information on the marginal parameters may result in underpowered trials for achieving the study objectives at a pre-specified significance level. We propose a general strategy for calculating the required sample size when the correlation is not specified and accounting for uncertainty in the marginal parameter values. We present the web platform CompARE to characterize composite endpoints and to calculate the sample size just as we propose in this paper. We evaluate the performance of the proposal with a simulation study and illustrate it by means of a real case study using CompARE., Peer Reviewed, Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The tryptophan system in cocaine-induced depression

  • Fonseca Casals, Francina, 1972-
  • Mestre-Pintó, Juan Ignacio
  • Gómez-Gómez, Àlex
  • Martínez-Sanvisens, Diana
  • Rodríguez-Minguela, Rocío
  • Papaseit Fontanet, Esther
  • Pérez Mañá, Clara
  • Langohr, Klaus
  • Valverde Granados, Olga
  • Pozo Mendoza, Óscar J., 1975-
  • Farré Albaladejo, Magí
  • Pérez Mañá, Clara
  • Neurodep Group
Major depression disorder (MDD) is the most prevalent psychiatric comorbid condition in cocaine use disorder (CUD). The comorbid MDD might be primary-MDD (CUD-primary-MDD) or cocaine-induced MDD (CUD-induced-MDD), and their accurate diagnoses and treatment is a challenge for improving prognoses. This study aimed to assess the tryptophan/serotonin (Trp/5-HT) system with the acute tryptophan depletion test (ATD), and the kynurenine pathway in subjects with CUD-primary-MDD, CUD-induced-MDD, MDD and healthy controls. The ATD was performed with a randomized, double-blind, crossover, and placebo-controlled design. Markers of enzymatic activity of indoleamine 2,3-dioxygenase/tryptophan 2,3-dioxygenase, kynurenine aminotransferase (KAT) and kynureninase were also established. Following ATD, we observed a decrease in Trp levels in all groups. Comparison between CUD-induced-MDD and MDD revealed significant differences in 5-HT plasma concentrations (512 + 332 ng/mL vs. 107 + 127 ng/mL, p = 0.039) and the Kyn/5-HT ratio (11 + 15 vs. 112 + 136; p = 0.012), whereas there were no differences between CUD-primary-MDD and MDD. Effect size coefficients show a gradient for all targeted markers (d range 0.72-1.67). Results suggest different pathogenesis for CUD-induced-MDD, with lower participation of the tryptophan system, probably more related to other neurotransmitter pathways and accordingly suggesting the need for a different pharmacological treatment approach., This work was supported by grants from the Instituto de Salud Carlos III–ISCIII Red de Trastornos Adictivos 2016 (RD16/0017/0010, RD16/0017/0003; Fondo de Investigación Sanitaria (FIS) (PI09/02121, PI12/01838, PI14/00178, PI16/00603); National R + D+I and funded by the Instituto de Salud Carlos III (ISCIII) and the European Regional Development Fund (FEDER) grant Juan Rodes (JR 16/00020); Ministerio de Sanidad, Política Social e Igualdad, Plan Nacional Sobre Drogas (PNSD) (2012I054); Suport Grups de Recerca AGAUR-Gencat (2017 SGR 316, 2017 SGR 530); Acció instrumental d’Intensificació de Professionals de la Salut - Facultatius especialistes (PERIS) (SLT006/17/00014); and Ministerio de Economía y Competitividad (MTM2015-64465-C2-1-R). The funding agencies had no role in study design, data collection, interpretation, or had influence on the writing.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

National citation patterns of NEJM, The Lancet, JAMA and The BMJ in the lay press: a quantitative content analysis

  • Casino, Gonzalo, 1961-
  • Rius, Roser
  • Cobo Valeri, Erik
Objectives: To analyse the total number of newspaper articles citing the four leading general medical journals and to describe national citation patterns.Design: Quantitative content analysis.Setting/sample: Full text of 22 general newspapers in 14 countries over the period 2008–2015, collected from LexisNexis. The 14 countries have been categorised into four regions: the USA, the UK, Western World (European countries other than the UK, and Australia, New Zealand and Canada) and Rest of the World (other countries). Main outcome measure: Press citations of four medical journals (two American: NEJM and JAMA; and two British: The Lancet and The BMJ) in 22 newspapers. Results: British and American newspapers cited some of the four analysed medical journals about three times a week in 2008–2015 (weekly mean 3.2 and 2.7 citations, respectively); the newspapers from other Western countries did so about once a week (weekly mean 1.1), and those from the Rest of the World cited them about once a month (monthly mean 1.1). The New York Times cited above all other newspapers (weekly mean 4.7). The analysis showed the existence of three national citation patterns in the daily press: American newspapers cited mostly American journals (70.0% of citations), British newspapers cited mostly British journals (86.5%) and the rest of the analysed press cited more British journals than American ones. The Lancet was the most cited journal in the press of almost all Western countries outside the USA and the UK. Multivariate correspondence analysis confirmed the national patterns and showed that over 85% of the citation data variability is retained in just one single new variable: the national dimension. Conclusion: British and American newspapers are the ones that cite the four analysed medical journals more often, showing a domestic preference for their respective national journals; non-British and non-American newspapers show a common international citation pattern., RR and EC belong to MiRoR (Methods in Research on Research), which has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 676207. EC is partially supported by grants MTM2015-64465-C2-1-R (MINECO/FEDER) from the Ministerio de Economía y Competitividad (Spain), and 2014 SGR 464 from the Departament d’Economia i Coneixement de la Generalitat de Catalunya.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

An iterative method to protect the type I error rate in bioequivalence studies under two-stage adaptive 2×2 crossover designs

  • Molins Lleonart, Eduard
  • Labes, Detlew
  • Schütz, Helmut
  • Cobo Valeri, Erik
  • Ocaña Rebull, Jordi
This is the peer reviewed version of the following article: Molins, E. [et al.]. An iterative method to protect the type I error rate in bioequivalence studies under two-stage adaptive 2×2 crossover designs. "Biometrical journal", 2021, vol. 63, núm. 1, p. 122-133., which has been published in final form at https://onlinelibrary.wiley.com/doi/10.1002/bimj.201900388. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving., Bioequivalence studies are the pivotal clinical trials submitted to regulatory agen- cies to support the marketing applications of generic drug products. Average bioequivalence (ABE) is used to determine whether the mean values for the pharmacokinetic measures determined after administration of the test and refer- ence products are comparable. Two-stage 2×2 crossover adaptive designs (TSDs) are becoming increasingly popular because they allow making assumptions on the clinically meaningful treatment effect and a reliable guess for the unknown within-subject variability. At an interim look, if ABE is not declared with an ini- tial sample size, they allow to increase it depending on the estimated variability and to enroll additional subjects at a second stage, or to stop for futility in case of poor likelihood of bioequivalence. This is crucial because both parameters must clearly be prespecified in protocols, and the strategy agreed with regulatory agen- cies in advance with emphasis on controlling the overall type I error. We present an iterative method to adjust the significance levels at each stage which preserves the overall type I error for a wide set of scenarios which should include the true unknown variability value. Simulations showed adjusted signif- icance levels higher than 0.0300 in most cases with type I error always below 5%, and with a power of at least 80%. TSDs work particularly well for coefficients of variation below 0.3 which are especially useful due to the balance between the power and the percentage of studies proceeding to stage 2. Our approach might support discussions with regulatory agencies., This research is partially supported by the grant MTM2015-64465-C2-1-R (MINECO/FEDER) from the Ministerio de Economia y Competitividad (Spain) and by the grant 2014 SGR 464 from the Generalitat de Catalunya., Peer Reviewed, Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

BDNF and cortisol in the diagnosis of cocaine-induced depression

  • Fonseca Casals, Francina, 1972-
  • Mestre-Pintó, Juan Ignacio
  • Rodríguez-Minguela, Rocío
  • Papaseit Fontanet, Esther
  • Pérez Mañá, Clara
  • Langohr, Klaus
  • Barbuti, Margherita
  • Farré Albaladejo, Magí
  • Torrens, Marta
  • Neurodep Group
Background: Major depressive disorder (MDD) and cocaine use disorder (CUD) are related with disability and high mortality rates. The assessment and treatment of psychiatric comorbidity is challenging due to its high prevalence and its clinical severity, mostly due to suicide rates and the presence of medical comorbidities. The aim of this study is to investigate differences in brain derived neurotrophic factor (BDNF) and cortisol plasmatic levels in patients diagnosed with CUD-primary-MDD and CUD-induced-MDD and also to compare them to a sample of MDD patients (without cocaine use), a sample of CUD (without MDD), and a group of healthy controls (HC) after a stress challenge. Methods: A total of 46 subjects were included: MDD (n = 6), CUD (n = 15), CUD-primary-MDD (n = 16), CUD-induced-MDD (n = 9), and 21 HC. Psychiatric comorbidity was assessed with the Spanish version of the Psychiatric Research Interview for Substance and Mental Disorders IV (PRISM-IV), and depression severity was measured with the Hamilton Depression Rating Scale (HDRS). Patients were administered the Trier Social Stress Test (TSST) before and after the biological measures, including BDNF, and cortisol levels were obtained. Results: After the TSST, Cohen's d values between CUD-primary-MDD and CUD-induced-MDD increased in each assessment from 0.19 post-TSST to 2.04 post-90-TSST. Pairwise differences among CUD-induced-MDD and both MDD and HC groups had also a large effect size value in post-30-TSST and post-90-TSST. In the case of the BDNF concentrations, CUD-primary-MDD and CUD-induced-MDD in post-90-TSST (12,627.27 ± 5488.09 vs.17,144.84 ± 6581.06, respectively) had a large effect size (0.77). Conclusion: Results suggest a different pathogenesis for CUD-induced-MDD with higher levels of cortisol and BDNF compared with CUD-primary-MDD. Such variations should imply different approaches in treatment., This work was supported by grants from the Instituto de Salud Carlos III–ISCIII Red de Trastornos Adictivos 2016 (RD16/0017/0010 and RD16/0017/0003); Fondo de Investigación Sanitaria (FIS) (PI09/02121, PI12/01838, PI16/00603); National R + D+I and funded by the Instituto de Salud Carlos III (ISCIII) and the European Regional Development Fund (FEDER) grant Juan Rodes (JR 16/00020); Ministerio de Sanidad, Política Social e Igualdad, Plan Nacional Sobre Drogas (PNSD) (2012I054); Suport Grups de Recerca AGAUR-Gencat (2017 SGR 316, 2017 SGR 530); Ministerio de Economía y Competitividad (MTM2015-64465-C2-1-R); ISCIII-Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS); Red de Investigación en Atención Primaria de Adicciones (RIAPAd), grant number RD21/0009/0001. The funding agencies had no role in study design, data collection, interpretation, and no influence on the writing.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Balances: a new perspective for microbiome analysis

  • Rivera Pinto, J.
  • Egozcue Rubí, Juan José
  • Pawlowsky Glahn, Vera
  • Paredes, Raul
  • Noguera Julian, Marc
  • Calle, M. L.
High-throughput sequencing technologies have revolutionized microbiome research by allowing the relative quantification of microbiome composition and function in different environments. In this work we focus on the identification of microbial signatures, groups of microbial taxa that are predictive of a phenotype of interest. We do this by acknowledging the compositional nature of the microbiome and the fact that it carries relative information. Thus, instead of defining a microbial signature as a linear combination in real space corresponding to the abundances of a group of taxa, we consider microbial signatures given by the geometric means of data from two groups of taxa whose relative abundances, or balance, are associated with the response variable of interest. In this work we present selbal, a greedy stepwise algorithm for selection of balances or microbial signatures that preserves the principles of compositional data analysis. We illustrate the algorithm with 16S rRNA abundance data from a Crohn’s microbiome study and an HIV microbiome study. We propose a new algorithm for the identification of microbial signatures. These microbial signatures can be used for diagnosis, prognosis, or prediction of therapeutic response based on an individual’s specific microbiota., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Decision tool and Sample Size Calculator for composite endpoints

  • Bofill Roig, Marta
  • Cortés Martínez, Jordi
  • Gómez Melis, Guadalupe
This article considers the combination of two binary or two time-to-event endpoints to form the primary composite endpoint for leading a trial. • It discusses the relative efficiency of choosing a composite endpoint over one of its components in terms of: the frequencies of observing each component; the relative treatment effect of the tested therapy; and the association between both components. • We highlight the very important role of the association between components in choosing the most efficient endpoint to use as primary. • For better grounded future trials, we recommend trialists to always reporting the association between components of the composite endpoint • Common fallacies to note when using composite endpoints: i) composite endpoints always imply higher power; ii) treatment effect on the composite endpoint is similar to the average effects of its components; and iii) the probability of observing the primary endpoint increases significantly., Peer Reviewed, Preprint
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Modeling the coronavirus disease 2019 incubation period: impact on quarantine policy

  • Pak, Daewoo
  • Langohr, Klaus
  • Ning, Jing
  • Cortés Martínez, Jordi
  • Gómez Melis, Guadalupe
  • Shen, Yu
The incubation period of coronavirus disease 2019 (COVID-19) is not always observed exactly due to uncertain onset times of infection and disease symptoms. In this paper, we demonstrate how to estimate the distribution of incubation and its association with patient demographic factors when the exact dates of infection and symptoms’ onset may not be observed. The findings from analysis of the confirmed COVID-19 cases indicate that age could be associated with the incubation period, and an age-specific quarantine policy might be more efficient than a unified one in confining COVID-19., This research was funded by the Ministerio de Ciencia e Innovación (Spain) (PID2019-104830RB-I00),the Ministerio de Economía y Competitividad (Spain) (MTM2015-64465-C2-1-R (MINECO/FEDER)), and theDepartament d’Economia i Coneixement de la Generalitat de Catalunya (Spain) (2017 SGR 622 (GRBIO))., Peer Reviewed, Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Short- and medium-term impact of bariatric surgery on the activities of CYP2D6, CYP3A4, CYP2C9, and CYP1A2 in morbid obesity

  • Rodríguez-Morató, Jose, 1987-
  • Goday Arnó, Albert
  • Langohr, Klaus
  • Pujadas Bastardes, Mitona
  • Civit, Ester
  • Pérez Mañá, Clara
  • Papaseit Fontanet, Esther
  • Ramon, Jose Manuel
  • Benaiges Foix, David
  • Castañer, Olga
  • Farré Albaladejo, Magí
  • Torre Fornell, Rafael de la
Morbid obesity and bariatric surgery induce anatomical, physiological and metabolic alterations that may alter the body's disposition of drugs. Current literature on this topic is limited and sometimes inconsistent. Cytochrome P450 (CYP) is a superfamily of enzymes that metabolize around 75% of all marketed drugs. The purpose of this study was to evaluate the impact of body mass index and bariatric surgery on CYP activities. Firstly, we evaluated the in vivo activity of 4 major CYP isoenzymes (CYP2D6, CYP3A4, CYP2C9, and CYP1A2) in normal weight, overweight, and morbidly obese individuals. Secondly, we assessed the short- (1 month) and medium-term (6 month) effects of the most commonly employed bariatric surgery techniques (laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass) on the activity of these enzymes. CYP3A4 activity was lower in morbidly obese individuals, compared to normal-weight controls. Interestingly, bariatric surgery normalized CYP3A4 activity. In comparison with normal-weight controls, morbidly obese individuals had higher CYP2D6 activity, which was only observed in individuals with two functional alleles for this isoenzyme. Neither body mass index nor surgery had significant effects on CYP2C9 and CYP1A2 activities. Overall, no relevant differences in CYP activities were found between surgical techniques. In conclusion, further studies should evaluate whether the observed alterations in CYP3A4 activity will require dose adjustments for CYP3A4 substrates especially in morbidly obese individuals before and after bariatric surgery., This work was supported by a grant from the Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias, FISS ETS PI08/90638 co-financed with European Union ERDF funds (European Regional Development Fund). It was also partially supported by grants MTM2015-64465-C2-1-R from the Ministerio de Economía y Competividad (Spain) and 2014 SGR 464 from the Departament d’Economia i Coneixement de la Generalitat de Catalunya (Spain). JRM acknowledges the EU Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant No. 712949 (TECNIOspring PLUS) from the Agency for Business Competitiveness of the Government of Catalonia. OCN and EPF had grants from ISCIII Juan Rodés JR17/00022 and JR 16/00020.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Mortality of NBA Players: risk factors and comparison with the general US population

  • Martínez García, Jose Antonio
  • Langohr, Klaus
  • Felipo, Julián
  • Casals Toquero, Martí
Concerns have been raised recently by players’ associations regarding the risk of death among retired players. Using a retrospective cohort study, we analyzed factors associated with the mortality of National Basketball Association (NBA) players and compared their life expectancy with that of the general population. We analyzed a cohort of 3985 players who participated in the NBA from its inception in 1946 to April 2015 (481 active and 3504 former players). We used the data for the 3504 former NBA players, of whom 687 (19.1%) died before 15 April 2015, to study the elapsed time between the end of their NBA careers until death. Cox proportional hazards models were employed in the multivariate survival analysis. After adjusting for age at the end of the NBA career and calendar year, we found that mortality is associated with height and ethnicity. Taller players and African-American players had a higher instantaneous risk of death than shorter players or white players. In addition, the life expectancy of players (regardless of height and ethnicity) has increased since the inception of the NBA. This is one of the first studies using such an extensive cohort of professional basketball players and Cox proportional hazards models. Results confirmed that height is associated with mortality. In addition, ethnicity is also linked to mortality; white players and small players live longer. Our study is useful for devising strategies for health interventions and the proper allocation of resources with respect to the general population., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Two-stage designs versus European scaled average designs in bioequivalence studies for highly variable drugs: which to choose?

  • Molins Lleonart, Eduard
  • Cobo Valeri, Erik
  • Ocaña Rebull, Jordi
This is the peer reviewed version of the following article: Molins, E., Cobo, E., Ocaña, J. Two-stage designs versus European scaled average designs in bioequivalence studies for highly variable drugs: which to choose?. "Statistics in medicine", Desembre 2017, vol. 36, núm. 30, p. 4777-4788, which has been published in final form at http://onlinelibrary.wiley.com/doi/10.1002/sim.7452/pdf. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving., The usual approach to determine bioequivalence for highly variable drugs is scaled average bioequivalence, which is based on expanding the limits as a function of the within-subject variability in the reference formulation. This requires separately estimating this variability and thus using replicated or semireplicated crossover designs. On the other hand, regulations also allow using common 2 × 2 crossover designs based on two-stage adaptive approaches with sample size reestimation at an interim analysis. The choice between scaled or two-stage designs is crucial and must be fully described in the protocol. Using Monte Carlo simulations, we show that both methodologies achieve comparable statistical power, though the scaled method usually requires less sample size, but at the expense of each subject being exposed more times to the treatments. With an adequate initial sample size (not too low, eg, 24 subjects), two-stage methods are a flexible and efficient option to consider: They have enough power (eg, 80%) at the first stage for non-highly variable drugs, and, if otherwise, they provide the opportunity to step up to a second stage that includes additional subjects., Peer Reviewed, Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

A vector scale of severity of damages in buildings

  • Ruiz Gorrindo, Félix
  • Aguado de Cea, Antonio
  • Serrat Piè, Carles
In the context of the existing buildings, along the recent years the concept of maintenance has changed from corrective maintenance to preventive maintenance, which is based in part on periodic inspections. There is ample evidence that preventive maintenance is more efficient than corrective maintenance, since severe deteriorations that may represent danger to people are avoided, and also money is saved. To make periodic inspections of the buildings is useful to quantify the extent to which deficiencies are severe or not, in order to facilitate decision making and prioritize therapeutic interventions. To this purpose many scales have been used and are used to assess the degree of gravity of the damages in constructive elements. But it is important to say that there is no common consensus and these scales are different between them according to the study to which they belong. Thus, the main goal of this article is to propose a methodology for calculating the degree of severity of damages in buildings, which is of widespread use. This calculation method, which is in distribution and in scalar, lets to calculate the severity index of systems and of the entire building, and it is easy to use and flexible., This research has been partially supported by grants MTM2015-64465-C2-1-R (MINECO / FEDER) from the Ministerio de Economía y Competitividad (Spain) and 2017 SGR 622 from the Departament d’Economia i Coneixement de la Generalitat de Catalunya. Authors are grateful to members of the IEMAE, LABEDI and GRASS-GRBIO groups their valuable comments and suggestions in the development of the work., Objectius de Desenvolupament Sostenible::11 - Ciutats i Comunitats Sostenibles, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A systematic review of sport-related packages within the R CRAN repository

  • Casals Toquero, Martí
  • Fernández, Jose
  • Martínez Rech, Víctor
  • López, Michael
  • Langohr, Klaus
  • Cortés Martínez, Jordi
© The Author(s) 2022, The sports statistics community is rapidly evolving. R is an open-source software in constant development that has gained a lot of popularity within statistical communities and sports analytics. This work presents a systematic review of the available R CRAN sport packages following PRISMA guidelines. We consider all packages active as of 18 February 2021. A total of 81 sport R packages created since 2006 were detected. Of these, 35.9% were authored by an American national, 69.1% include a dataset, 43.2% provide vignettes, and 65.4% have been updated at least once. The sport with the highest representation is basketball (n¿=¿14, 17.3%), followed by soccer (n¿=¿12, 14.8%) and packages related to physical activity (n¿=¿11, 13.6%). There are no sports packages directed solely for the female gender, while 59.3% of packages are focused on professional athletes. Fifty packages (61.7%) are related to the sports performance analysis category, and web scraping (n¿=¿43, 53.1%) was the main functionality in the collected packages. The creation of new R packages in the area of sports could help solve questions and tasks that still remain a challenge in this field, while continuing to help to improve the level of statistical education and computational thinking skills., The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was funded by the Ministerio de Ciencia e Innovación (Spain) (PID2019-104830RB-I00) and the Departament d’Economia i Coneixement de la Generalitat de Catalunya (Spain) (2017 SGR 622 (GRBIO))., Peer Reviewed, Postprint (author's final draft)
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection

  • Guillén, Yolanda|||0000-0001-8673-6470
  • Noguera-Julian, Marc|||0000-0002-6194-1395
  • Rivera Pinto, Javier|||0000-0002-4427-6442
  • Casadellà, Maria|||0000-0002-4115-2305
  • Zevin, Alexander
  • Rocafort, M.
  • Parera, M.
  • Rodríguez Rügnitz, M. Cristina
  • Arumí Rovira, Marçal
  • Carrillo, Jorge|||0000-0003-0221-5948
  • Mothe, Beatriz|||0000-0001-9975-407X
  • Estany Quera, Carla|||0000-0001-6993-5865
  • Coll, Josep
  • Bravo, Isabel
  • Herrero, Cristina
  • Saz, Jorge|||0000-0002-8679-634X
  • Sirera, Guillem|||0000-0003-4014-9355
  • Torrella Domingo, Adriana|||0000-0003-1848-5096
  • Navarro, Jordi|||0000-0002-7187-0367
  • Crespo Casal, Manuel|||0000-0001-9016-0515
  • Negredo Puigmal, Eugènia|||0000-0001-5298-1734
  • Brander, Christian|||0000-0002-0548-5778
  • Blanco, Julià|||0000-0002-2225-0217
  • Calle, M. Luz|||0000-0001-9334-415X
  • Klatt, N. R.
  • Pérez-Álvarez, Núria|||0000-0001-6582-1553
  • Paredes, Roger|||0000-0002-6553-691X
Human immunodeficiency virus (HIV)-1 infection causes severe gut and systemic immune damage, but its effects on the gut microbiome remain unclear. Previous shotgun metagenomic studies in HIV-negative subjects linked low-microbial gene counts (LGC) to gut dysbiosis in diseases featuring intestinal inflammation. Using a similar approach in 156 subjects with different HIV-1 phenotypes, we found a strong, independent, dose-effect association between nadir CD4+ T-cell counts and LGC. As in other diseases involving intestinal inflammation, the gut microbiomes of subjects with LGC were enriched in gram-negative Bacteroides, acetogenic bacteria and Proteobacteria, which are able to metabolize reactive oxygen and nitrogen species; and were depleted in oxygen-sensitive methanogenic archaea and sulfate-reducing bacteria. Interestingly, subjects with LGC also showed increased butyrate levels in direct fecal measurements, consistent with enrichment in Roseburia intestinalis despite reductions in other butyrate producers. The microbiomes of subjects with LGC were also enriched in bacterial virulence factors, as well as in genes associated with beta-lactam, lincosamide, tetracycline, and macrolide resistance. Thus, low nadir CD4+ T-cell counts, rather than HIV-1 serostatus per se, predict the presence of gut dysbiosis in HIV-1 infected subjects. Such dysbiosis does not display obvious HIV-specific features; instead, it shares many similarities with other diseases featuring gut inflammation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Short- and medium-term impact of bariatric surgery on the activities of CYP2D6, CYP3A4, CYP2C9, and CYP1A2 in morbid obesity

  • Rodríguez-Morató, Jose|||0000-0002-8133-9983
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Langohr, Klaus|||0000-0001-7075-9192
  • Pujadas, Mitona|||0000-0002-0506-3030
  • Civit, Ester
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Papaseit, Esther|||0000-0003-2620-4274
  • Ramon, Jose Manuel
  • Benaiges, David|||0000-0001-5411-364X
  • Castañer, Olga|||0000-0003-3169-997X
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Torre, Rafael de la|||0000-0002-6765-1866
Morbid obesity and bariatric surgery induce anatomical, physiological and metabolic alterations that may alter the body's disposition of drugs. Current literature on this topic is limited and sometimes inconsistent. Cytochrome P450 (CYP) is a superfamily of enzymes that metabolize around 75% of all marketed drugs. The purpose of this study was to evaluate the impact of body mass index and bariatric surgery on CYP activities. Firstly, we evaluated the in vivo activity of 4 major CYP isoenzymes (CYP2D6, CYP3A4, CYP2C9, and CYP1A2) in normal weight, overweight, and morbidly obese individuals. Secondly, we assessed the short- (1 month) and medium-term (6 month) effects of the most commonly employed bariatric surgery techniques (laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass) on the activity of these enzymes. CYP3A4 activity was lower in morbidly obese individuals, compared to normal-weight controls. Interestingly, bariatric surgery normalized CYP3A4 activity. In comparison with normal-weight controls, morbidly obese individuals had higher CYP2D6 activity, which was only observed in individuals with two functional alleles for this isoenzyme. Neither body mass index nor surgery had significant effects on CYP2C9 and CYP1A2 activities. Overall, no relevant differences in CYP activities were found between surgical techniques. In conclusion, further studies should evaluate whether the observed alterations in CYP3A4 activity will require dose adjustments for CYP3A4 substrates especially in morbidly obese individuals before and after bariatric surgery.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Evolution of the gut microbiome following acute HIV-1 infection

  • Rocafort, Muntsa|||0000-0002-2991-1444
  • Noguera-Julian, Marc|||0000-0002-6194-1395
  • Rivera Pinto, Javier|||0000-0002-4427-6442
  • Pastor Palomo, Lucía|||0000-0002-8346-514X
  • Guillén, Yolanda|||0000-0001-8673-6470
  • Langhorst, Jost
  • Parera, Mariona|||0000-0002-0756-8307
  • Mandomando, Inacio|||0000-0002-1078-2187
  • Carrillo, Jorge|||0000-0003-0221-5948
  • Urrea, Víctor|||0000-0002-2577-856X
  • Rodríguez Rügnitz, M. Cristina
  • Casadellà, Maria|||0000-0002-4115-2305
  • Calle, M. Luz|||0000-0001-9334-415X
  • Pérez-Álvarez, Núria|||0000-0001-6582-1553
  • Blanco, Julià|||0000-0002-2225-0217
  • Naniche, Denise|||0000-0002-4495-6325
  • Paredes, Roger|||0000-0002-6553-691X
In rhesus macaques, simian immunodeficiency virus infection is followed by expansion of enteric viruses but has a limited impact on the gut bacteriome. To understand the longitudinal effects of HIV-1 infection on the human gut microbiota, we prospectively followed 49 Mozambican subjects diagnosed with recent HIV-1 infection (RHI) and 54 HIV-1-negative controls for 9-18 months and compared them with 98 chronically HIV-1-infected subjects treated with antiretrovirals (n = 27) or not (n = 71). We show that RHI is followed by increased fecal adenovirus shedding, which persists during chronic HIV-1 infection and does not resolve with ART. Recent HIV-1 infection is also followed by transient non-HIV-specific changes in the gut bacterial richness and composition. Despite early resilience to change, an HIV-1-specific signature in the gut bacteriome-featuring depletion of Akkermansia, Anaerovibrio, Bifidobacterium, and Clostridium- previously associated with chronic inflammation, CD8+ T cell anergy, and metabolic disorders, can be eventually identified in chronically HIV-1-infected subjects. Recent HIV-1 infection is associated with increased fecal shedding of eukaryotic viruses, transient loss of bacterial taxonomic richness, and long-term reductions in microbial gene richness. An HIV-1-associated microbiome signature only becomes evident in chronically HIV-1-infected subjects. The online version of this article (10.1186/s40168-019-0687-5) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Adherence to reporting guidelines increases the number of citations, the argument for including a methodologist in the editorial process and peer-review

  • Vilaró, Marta|||0000-0001-5692-0891
  • Cortés, Jordi|||0000-0002-3764-0795
  • Selva O'Callaghan, Albert|||0000-0003-2823-9761
  • Urrutia de Diego, Agustín|||0000-0002-7508-5091
  • Ribera, Jose-Maria|||0000-0003-1042-6024
  • Cardellach, Francesc|||0000-0003-3286-3436
  • Basagaña, X|||0000-0002-8457-1489
  • Elmore, Matthew
  • Vilardell, Miquel
  • Altman, Douglas G|||0000-0002-7183-4083
  • González, José-Antonio
  • Cobo, Erik
From 2005 to 2010, we conducted 2 randomized studies on a journal (Medicina Clínica), where we took manuscripts received for publication and randomly assigned them to either the standard editorial process or to additional processes. Both studies were based on the use of methodological reviewers and reporting guidelines (RG). Those interventions slightly improved the items reported on the Manuscript Quality Assessment Instrument (MQAI), which assesses the quality of the research report. However, masked evaluators were able to guess the allocated group in 62% (56/90) of the papers, thus presenting a risk of detection bias. In this post-hoc study, we analyse whether those interventions that were originally designed for improving the completeness of manuscript reporting may have had an effect on the number of citations, which is the measured outcome that we used. Masked to the intervention group, one of us used the Web of Science (WoS) to quantify the number of citations that the participating manuscripts received up December 2016. We calculated the mean citation ratio between intervention arms and then quantified the uncertainty of it by means of the Jackknife method, which avoids assumptions about the distribution shape. Our study included 191 articles (99 and 92, respectively) from the two previous studies, which all together received 1336 citations. In both studies, the groups subjected to additional processes showed higher averages, standard deviations and annual rates. The intervention effect was similar in both studies, with a combined estimate of a 43% (95% CI: 3 to 98%) increase in the number of citations. We interpret that those effects are driven mainly by introducing into the editorial process a senior methodologist to find missing RG items. Those results are promising, but not definitive due to the exploratory nature of the study and some important caveats such as: the limitations of using the number of citations as a measure of scientific impact; and the fact that our study is based on a single journal. We invite journals to perform their own studies to ascertain whether or not scientific repercussion is increased by adhering to reporting guidelines and further involving statisticians in the editorial process. The online version of this article (10.1186/s12874-019-0746-4) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Balances, a New Perspective for Microbiome Analysis

  • Rivera Pinto, Javier|||0000-0002-4427-6442
  • Egozcue, Juan José|||0000-0002-5144-4483
  • Pawlowsky-Glahn, Vera|||0000-0001-9775-6434
  • Paredes, Roger|||0000-0002-6553-691X
  • Noguera-Julian, Marc|||0000-0002-6194-1395
  • Calle, M. Luz|||0000-0001-9334-415X
We propose a new algorithm for the identification of microbial signatures. These microbial signatures can be used for diagnosis, prognosis, or prediction of therapeutic response based on an individual's specific microbiota. High-throughput sequencing technologies have revolutionized microbiome research by allowing the relative quantification of microbiome composition and function in different environments. In this work we focus on the identification of microbial signatures, groups of microbial taxa that are predictive of a phenotype of interest. We do this by acknowledging the compositional nature of the microbiome and the fact that it carries relative information. Thus, instead of defining a microbial signature as a linear combination in real space corresponding to the abundances of a group of taxa, we consider microbial signatures given by the geometric means of data from two groups of taxa whose relative abundances, or balance, are associated with the response variable of interest. In this work we present selbal, a greedy stepwise algorithm for selection of balances or microbial signatures that preserves the principles of compositional data analysis. We illustrate the algorithm with 16S rRNA abundance data from a Crohn's microbiome study and an HIV microbiome study.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV control

  • Oriol-Tordera, Bruna|||0000-0002-2714-9097
  • Berdasco, Maria|||0000-0002-6750-0400
  • Llano Montero, Anuska|||0000-0002-0133-9888
  • Mothe, Beatriz|||0000-0001-9975-407X
  • Gálvez, Cristina|||0000-0002-2286-6193
  • Martínez Picado, Francisco Javier|||0000-0002-4916-2129
  • Carrillo, Jorge|||0000-0003-0221-5948
  • Blanco, Julià|||0000-0002-2225-0217
  • Duran-Castells, Clara|||0000-0002-4034-5738
  • Ganoza, C.
  • Sanchez, Jorge
  • Pérez-Álvarez, Núria|||0000-0001-6582-1553
  • Calle, M. Luz|||0000-0001-9334-415X
  • Sánchez, Alex|||0000-0002-8673-7737
  • Esteller, M.|||0000-0003-4490-6093
  • Brander, Christian|||0000-0002-0548-5778
  • Ruiz Riol, Marta|||0000-0003-1899-8879
GWAS, immune analyses and biomarker screenings have identified host factors associated with in vivo HIV-1 control. However, there is a gap in the knowledge about the mechanisms that regulate the expression of such host factors. Here, we aimed to assess DNA methylation impact on host genome in natural HIV-1 control. To this end, whole DNA methylome in 70 untreated HIV-1 infected individuals with either high (.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals, Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02)

  • Mothe, Beatriz|||0000-0001-9975-407X
  • Rosás-Umbert, Miriam|||0000-0002-2850-6586
  • Coll, Pep
  • Manzardo, Christian
  • Puertas, Maria C.|||0000-0002-6750-2318
  • Moron-Lopez, Sara|||0000-0003-0800-9205
  • Llano Montero, Anuska|||0000-0002-0133-9888
  • Miranda, Cristina
  • Cedeño, Samandhy|||0000-0001-8312-0208
  • López, Miriam
  • Alarcón-Soto, Yovaninna|||0000-0002-9977-8634
  • Melis, Guadalupe Gómez
  • Langohr, Klaus|||0000-0001-7075-9192
  • Barriocanal, Ana María|||0000-0002-4159-519X
  • Toro, Jessica
  • Ruiz, Irene
  • Rovira, Cristina
  • Carrillo, Antonio
  • Meulbroek, Michael
  • Crook, Alison
  • Wee, Edmund G.
  • Miró, José M.|||0000-0001-8057-7755
  • Clotet Sala, Bonaventura|||0000-0003-3232-4598
  • Valle, Marta|||0000-0002-3515-251X
  • Martínez Picado, Francisco Javier|||0000-0002-4916-2129
  • Hanke, Tomáš|||0000-0002-6076-9546
  • Brander, Christian|||0000-0002-0548-5778
  • Moltó, José|||0000-0003-4564-1963
Kick&kill strategies combining drugs aiming to reactivate the viral reservoir with therapeutic vaccines to induce effective cytotoxic immune responses hold potential to achieve a functional cure for HIV-1 infection. Here, we report on an open-label, single-arm, phase I clinical trial, enrolling 15 early-treated HIV-1-infected individuals, testing the combination of the histone deacetylase inhibitor romidepsin as a latency-reversing agent and the MVA.HIVconsv vaccine. Romidepsin treatment resulted in increased histone acetylation, cell-associated HIV-1 RNA, and T-cell activation, which were associated with a marginally significant reduction of the viral reservoir. Vaccinations boosted robust and broad HIVconsv-specific T cells, which were strongly refocused toward conserved regions of the HIV-1 proteome. During a monitored ART interruption phase using plasma viral load over 2,000 copies/ml as a criterium for ART resumption, 23% of individuals showed sustained suppression of viremia up to 32 weeks without evidence for reseeding the viral reservoir. Results from this pilot study show that the combined kick&kill intervention was safe and suggest a role for this strategy in achieving an immune-driven durable viremic control.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Tryptophan System in Cocaine-Induced Depression

  • Fonseca, Francina|||0000-0002-0779-6545
  • Mestre-Pintó, Joan-Ignasi|||0000-0003-0387-9375
  • Gomez-Gomez, A.|||0000-0001-8172-1827
  • Martinez-Sanvisens, Diana
  • Rodríguez-Minguela, Rocío
  • Papaseit, Esther|||0000-0003-2620-4274
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Langohr, Klaus|||0000-0001-7075-9192
  • Valverde, Olga|||0000-0003-2264-7852
  • Pozo, Oscar J.|||0000-0002-1735-9728
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Torrens, Marta
Major depression disorder (MDD) is the most prevalent psychiatric comorbid condition in cocaine use disorder (CUD). The comorbid MDD might be primary-MDD (CUD-primary-MDD) or cocaine-induced MDD (CUD-induced-MDD), and their accurate diagnoses and treatment is a challenge for improving prognoses. This study aimed to assess the tryptophan/serotonin (Trp/5-HT) system with the acute tryptophan depletion test (ATD), and the kynurenine pathway in subjects with CUD-primary-MDD, CUD-induced-MDD, MDD and healthy controls. The ATD was performed with a randomized, double-blind, crossover, and placebo-controlled design. Markers of enzymatic activity of indoleamine 2,3-dioxygenase/tryptophan 2,3-dioxygenase, kynurenine aminotransferase (KAT) and kynureninase were also established. Following ATD, we observed a decrease in Trp levels in all groups. Comparison between CUD-induced-MDD and MDD revealed significant differences in 5-HT plasma concentrations (512 + 332 ng/mL vs. 107 + 127 ng/mL, p = 0.039) and the Kyn/5-HT ratio (11 + 15 vs. 112 + 136; p = 0.012), whereas there were no differences between CUD-primary-MDD and MDD. Effect size coefficients show a gradient for all targeted markers (d range 0.72-1.67). Results suggest different pathogenesis for CUD-induced-MDD, with lower participation of the tryptophan system, probably more related to other neurotransmitter pathways and accordingly suggesting the need for a different pharmacological treatment approach.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers

  • Vesterbacka, Jan
  • Rivera, Javier
  • Noyan, Kajsa
  • Parera, Mariona|||0000-0002-0756-8307
  • Neogi, Ujjwal
  • Calle, M. Luz|||0000-0001-9334-415X
  • Paredes, Roger|||0000-0002-6553-691X
  • Sönnerborg, Anders
  • Noguera-Julian, Marc|||0000-0002-6194-1395
  • Nowak, Piotr|||0000-0003-2747-0734
Gut microbiota dysbiosis features progressive HIV infection and is a potential target for intervention. Herein, we explored the microbiome of 16 elite controllers (EC), 32 antiretroviral therapy naive progressors and 16 HIV negative controls. We found that the number of observed genera and richness indices in fecal microbiota were significantly higher in EC versus naive. Genera Succinivibrio, Sutterella, Rhizobium, Delftia, Anaerofilum and Oscillospira were more abundant in EC, whereas Blautia and Anaerostipes were depleted. Additionally, carbohydrate metabolism and secondary bile acid synthesis pathway related genes were less represented in EC. Conversely, fatty acid metabolism, PPAR-signalling and lipid biosynthesis proteins pathways were enriched in EC vs naive. The kynurenine pathway of tryptophan metabolism was altered during progressive HIV infection, and inversely associated with microbiota richness. In conclusion, EC have richer gut microbiota than untreated HIV patients, with unique bacterial signatures and a distinct metabolic profile which may contribute to control of HIV.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B

  • Rosás-Umbert, Miriam|||0000-0002-2850-6586
  • Mothe, Beatriz|||0000-0001-9975-407X
  • Noguera-Julian, Marc|||0000-0002-6194-1395
  • Bellido, Rocío
  • Puertas, Maria C.|||0000-0002-6750-2318
  • Carrillo, Jorge|||0000-0003-0221-5948
  • Rodriguez, C.
  • Pérez-Álvarez, Núria|||0000-0001-6582-1553
  • Cobarsi, Patricia|||0000-0003-3977-230X
  • Gómez, Carmen Elena
  • Esteban, Mariano|||0000-0003-0846-2827
  • Jímenez, Jose Luis
  • García, Felipe|||0000-0001-7658-5832
  • Blanco, Julià|||0000-0002-2225-0217
  • Martínez Picado, Francisco Javier|||0000-0002-4916-2129
  • Paredes, Roger|||0000-0002-6553-691X
  • Brander, Christian|||0000-0002-0548-5778
The most relevant endpoint in therapeutic HIV vaccination is the assessment of time to viral rebound or duration of sustained control of low-level viremia upon cART treatment cessation. Structured treatment interruptions (STI) are however not without risk to the patient and reliable predictors of viral rebound/control after therapeutic HIV-1 vaccination are urgently needed to ensure patient safety and guide therapeutic vaccine development. Here, we integrated immunological and virological parameters together with viral rebound dynamics after STI in a phase I therapeutic vaccine trial of a polyvalent MVA-B vaccine candidate to define predictors of viral control. Clinical parameters, proviral DNA, host HLA genetics and measures of humoral and cellular immunity were evaluated. A sieve effect analysis was conducted comparing pre-treatment viral sequences to breakthrough viruses after STI. Our results show that a reduced proviral HIV-1 DNA at study entry was independently associated with two virological parameters, delayed HIV-1 RNA rebound (p = 0.029) and lower peak viremia after treatment cessation (p = 0.019). Reduced peak viremia was also positively correlated with a decreased number of HLA class I allele associated polymorphisms in Gag sequences in the rebounding virus population (p = 0.012). Our findings suggest that proviral DNA levels and the number of HLA-associated Gag polymorphisms may have an impact on the clinical outcome of STI. Incorporation of these parameters in future therapeutic vaccine trials may guide refined immunogen design and help conduct safer STI approaches.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

In Vivo, Non-Invasive Characterization of Human Bone by Hybrid Broadband (600-1200 nm) Diffuse Optical and Correlation Spectroscopies

  • Konugolu Venkata Sekar, Sanathana|||0000-0003-0912-1282
  • Pagliazzi, Marco
  • Negredo Puigmal, Eugènia|||0000-0001-5298-1734
  • Martelli, Fabrizio
  • Farina, Andrea
  • Dalla Mora, Alberto
  • Lindner, Claus|||0000-0002-9878-037X
  • Farzam, Parisa
  • Pérez-Álvarez, Núria|||0000-0001-6582-1553
  • Puig, Jordi|||0000-0002-4075-0346
  • Taroni, Paola
  • Pifferi, Antonio
  • Durduran, Turgut|||0000-0001-5838-1027
Non-invasive in vivo diffuse optical characterization of human bone opens a new possibility of diagnosing bone related pathologies. We present an in vivo characterization performed on seventeen healthy subjects at six different superficial bone locations: radius distal, radius proximal, ulna distal, ulna proximal, trochanter and calcaneus. A tailored diffuse optical protocol for high penetration depth combined with the rather superficial nature of considered tissues ensured the effective probing of the bone tissue. Measurements were performed using a broadband system for Time-Resolved Diffuse Optical Spectroscopy (TRS) to assess mean absorption and reduced scattering spectra in the 600-1200 nm range and Diffuse Correlation Spectroscopy (DCS) to monitor microvascular blood flow. Significant variations among tissue constituents were found between different locations; with radius distal rich of collagen, suggesting it as a prominent location for bone related measurements, and calcaneus bone having highest blood flow among the body locations being considered. By using TRS and DCS together, we are able to probe the perfusion and oxygen consumption of the tissue without any contrast agents. Therefore, we predict that these methods will be able to evaluate the impairment of the oxygen metabolism of the bone at the point-of-care.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection

  • Prats, Anna|||0000-0002-3586-4525
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • Mothe, Beatriz|||0000-0001-9975-407X
  • Negredo Puigmal, Eugènia|||0000-0001-5298-1734
  • Pérez-Álvarez, Núria|||0000-0001-6582-1553
  • Garolera, Maite
  • Domenech, Sira|||0000-0002-5700-768X
  • Coll, Pep
  • Meulbroek, Michael
  • Chamorro, Anna
  • Fumaz, Carmina R.|||0000-0003-0838-3395
  • Ferrer, Maria Jose
  • Clotet Sala, Bonaventura|||0000-0003-3232-4598
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Muñoz-Moreno, José Antonio|||0000-0002-7239-5422
Integrase strand transfer inhibitors (INSTI) are a main component of the current antiretroviral regimens recommended for treatment of HIV infection. However, little is known about the impact of INSTI on neurocognition and neuroimaging. We developed a prospective observational trial to evaluate the effects of INSTI-based antiretroviral therapy on comprehensive brain outcomes (cognitive, functional, and imaging) according to the time since HIV-1 acquisition. We recruited men living with HIV who initiated antiretroviral therapy with INSTI < 3 months since the estimated date of HIV-1 acquisition (n = 12) and.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression

  • Fonseca, Francina|||0000-0002-0779-6545
  • Mestre-Pintó, Joan-Ignasi|||0000-0003-0387-9375
  • Rodríguez-Minguela, Rocío
  • Papaseit, Esther|||0000-0003-2620-4274
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Langohr, Klaus|||0000-0001-7075-9192
  • Barbuti, Margherita
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Torrens, Marta
Major depressive disorder (MDD) and cocaine use disorder (CUD) are related with disability and high mortality rates. The assessment and treatment of psychiatric comorbidity is challenging due to its high prevalence and its clinical severity, mostly due to suicide rates and the presence of medical comorbidities. The aim of this study is to investigate differences in brain derived neurotrophic factor (BDNF) and cortisol plasmatic levels in patients diagnosed with CUD-primary-MDD and CUD-induced-MDD and also to compare them to a sample of MDD patients (without cocaine use), a sample of CUD (without MDD), and a group of healthy controls (HC) after a stress challenge. A total of 46 subjects were included: MDD (n = 6), CUD (n = 15), CUD-primary-MDD (n = 16), CUD-induced-MDD (n = 9), and 21 HC. Psychiatric comorbidity was assessed with the Spanish version of the Psychiatric Research Interview for Substance and Mental Disorders IV (PRISM-IV), and depression severity was measured with the Hamilton Depression Rating Scale (HDRS). Patients were administered the Trier Social Stress Test (TSST) before and after the biological measures, including BDNF, and cortisol levels were obtained. After the TSST, Cohen's d values between CUD-primary-MDD and CUD-induced-MDD increased in each assessment from 0.19 post-TSST to 2.04 post-90-TSST. Pairwise differences among CUD-induced-MDD and both MDD and HC groups had also a large effect size value in post-30-TSST and post-90-TSST. In the case of the BDNF concentrations, CUD-primary-MDD and CUD-induced-MDD in post-90-TSST (12,627.27 ± 5488.09 vs.17,144.84 ± 6581.06, respectively) had a large effect size (0.77). Results suggest a different pathogenesis for CUD-induced-MDD with higher levels of cortisol and BDNF compared with CUD-primary-MDD. Such variations should imply different approaches in treatment.